Breast cancer screening for women aged 40-49 years: screening may not be the benign process usually thought

J Natl Cancer Inst. 2001 Oct 17;93(20):1572. doi: 10.1093/jnci/93.20.1572.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Biopsy
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Canada
  • Consensus Development Conferences, NIH as Topic
  • Disease Progression
  • Endothelial Growth Factors / blood
  • Female
  • Growth Substances / metabolism
  • Humans
  • Lymphatic Metastasis
  • Lymphokines / blood
  • Mammography
  • Mass Screening / adverse effects*
  • Mastectomy / adverse effects*
  • Menstrual Cycle
  • Middle Aged
  • Models, Biological
  • Neovascularization, Pathologic / etiology*
  • Premenopause
  • Progesterone / blood
  • Randomized Controlled Trials as Topic
  • United States
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Growth Substances
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Progesterone